Royalty Pharma Plc Cl A (RPRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.70 +0.20 (+0.60%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.85 +0.15 (+0.45%) 19:29 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | RPRX | SYF | EQH | ||
| Company | Royalty Pharma Plc Cl A | Synchrony Financial | Axa Equitable Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 33.30 | 53.27 | 51.67 | ||
| High | 33.84 | 54.18 | 52.60 | ||
| Low | 33.25 | 52.50 | 51.26 | ||
| Last | 33.70 | 54.02 | 52.55 | ||
| Change | +0.20 | +0.15 | +0.14 | ||
| % Change | +0.60% | +0.28% | +0.27% | ||
| Volume | 7,065,500 | 6,429,700 | 12,672,400 | ||
| 20-Day Average Volume | 4,069,035 | 5,307,465 | 3,443,805 | ||
| Previous Close | 33.50 | 53.87 | 52.41 | ||
| Industry | Finance - Misc Services | Finance - Misc Services | Finance - Misc Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.28 | 55.53 | 52.08 | ||
| 20-Day Raw Stochastic | 77.27% | 28.35% | 57.60% | ||
| 20-Day Relative Strength | 64.24% | 37.64% | 51.74% | ||
| Weighted Alpha | +21.25 | +18.73 | +43.16 | ||
| Today's Opinion | 100% Buy | 56% Sell | 64% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.84% since 03/14/25 | +1.27% since 03/14/25 | +2.50% since 03/14/25 | ||
| Low | 32.73 on 03/17/25 | 52.06 on 03/17/25 | 50.40 on 03/17/25 | ||
| High | 33.84 on 03/21/25 | 55.25 on 03/20/25 | 53.44 on 03/19/25 | ||
| 1-Month | |||||
| %Chg | +0.84% since 02/21/25 | -12.03% since 02/21/25 | +2.30% since 02/21/25 | ||
| Low | 32.00 on 03/12/25 | 50.87 on 03/10/25 | 47.89 on 03/07/25 | ||
| High | 34.20 on 02/24/25 | 61.98 on 02/24/25 | 55.98 on 03/03/25 | ||
| 3-Month | |||||
| %Chg | +35.23% since 12/20/24 | -17.46% since 12/20/24 | +12.96% since 12/20/24 | ||
| Low | 24.46 on 12/23/24 | 50.87 on 03/10/25 | 46.05 on 12/23/24 | ||
| High | 34.20 on 02/24/25 | 70.93 on 01/23/25 | 56.00 on 02/19/25 | ||
| 6-Month | |||||
| %Chg | +22.37% since 09/20/24 | +6.80% since 09/20/24 | +24.79% since 09/20/24 | ||
| Low | 24.05 on 12/19/24 | 47.59 on 09/24/24 | 40.81 on 10/01/24 | ||
| High | 34.20 on 02/24/25 | 70.93 on 01/23/25 | 56.00 on 02/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,426,466 | 21,000,276 | 16,175,941 | ||
| Shares Outstanding, K | 576,453 | 388,750 | 307,820 | ||
| Annual Sales | 2,263,580,000 | 24,166,000,000 | 12,437,000,000 | ||
| Annual Net Income | 858,980,000 | 3,499,000,000 | 1,307,000,000 | ||
| Last Quarter Sales | 593,640,000 | 5,838,000,000 | 3,621,000,000 | ||
| Last Quarter Net Income | 208,210,000 | 774,000,000 | 899,000,000 | ||
| 60-Month Beta | 0.47 | 1.67 | 1.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.15 on 02/11/25 | 1.91 on 01/28/25 | 1.57 on 02/05/25 | ||
| Latest Earnings Date | 05/08/25 | 04/23/25 | 04/29/25 | ||
| Most Recent Dividend | 0.220 on 02/21/25 | 0.250 on 02/03/25 | 0.240 on 03/05/25 | ||
| Next Ex-Dividends Date | 02/21/25 | 02/03/25 | 03/05/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 8.11 | 8.19 | 8.79 | ||